HALEY MILLIGAN: Open Payments
NPI 1164013231 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 59 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $621 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $386 |
| Novartis Pharmaceuticals Corporation | 29 | $262 |
| Alnylam Pharmaceuticals Inc. | 6 | $128 |
| Novo Nordisk Inc | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Olympus America Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: CAMZYOS, LEQVIO, AMVUTTRA, Wegovy, JARDIANCE, Kerendia, ELIQUIS, Attruby.
Industry payments across TN — which companies pay providers there.
